November 2021: Netherlands Update

Information on EU Clinical Trial Regulation available on CCMO’s website

On 31 January 2022, the EU Clinical Trial Regulation (CTR) 536/2014 will apply in the European Union. All required information for investigators is available on the Central Committee on Research Involving Human Subjects (CCMO) website in a special section for research with medicinal products in accordance with the CTR.

The section consists of six parts:

The information is currently only available in English. A Dutch translation will be published soon.

The CTR replaces the current Clinical Trials Directive 2001/20/EC, which has been embedded in the Dutch Medical Research Involving Human Subjects Act (WMO). In contrast to the Clinical Trials Directive, the CTR stipulates that the procedures for the submission, assessment and conduct of research with medicinal products are the same throughout the EU. A transition period of three years applies. Partly due to the transition period for the CTR, the page Guide to the review procedure has been revised. Here you can find information on the legal frameworks and procedures for medical research, including research with medicinal products.